GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaCielo Ltd (TSXV:PCLO) » Definitions » Total Equity

PharmaCielo (TSXV:PCLO) Total Equity : C$2.79 Mil (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is PharmaCielo Total Equity?

PharmaCielo's total equity for the quarter that ended in Sep. 2023 was C$2.79 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

PharmaCielo Total Equity Historical Data

The historical data trend for PharmaCielo's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCielo Total Equity Chart

PharmaCielo Annual Data
Trend Aug17 Aug18 Dec19 Dec20 Dec21 Dec22
Total Equity
Get a 7-Day Free Trial 0.19 45.47 26.25 19.33 6.39

PharmaCielo Quarterly Data
Nov18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.16 6.39 4.38 3.56 2.79

PharmaCielo Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

PharmaCielo's Total Equity for the fiscal year that ended in Dec. 2022 is calculated as

Total Equity=Total Assets(Q: Dec. 2022 )-Total Liabilities(Q: Dec. 2022 )
=25.116-18.724
=6.39

PharmaCielo's Total Equity for the quarter that ended in Sep. 2023 is calculated as

Total Equity=Total Assets(Q: Sep. 2023 )-Total Liabilities(Q: Sep. 2023 )
=26.641-23.855
=2.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCielo Total Equity Related Terms

Thank you for viewing the detailed overview of PharmaCielo's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaCielo (TSXV:PCLO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaCielo Ltd (TSXV:PCLO) » Definitions » Total Equity
Comparable Companies
XCNQ:TIUM.U TSXV:CANB TSX:LABS TSX:AVCN XCNQ:BNXT TSXV:LSL XCNQ:GDNS XCNQ:GWAY XCNQ:ACRG.A.U TSX:AVNT ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
PCLOF:USA
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Website
https://www.pharmacielo.com
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of the revenue in the form of the Sale of Cannabis derivative products in Colombia.
Executives
Ian D Atacan Director, Senior Officer

PharmaCielo (TSXV:PCLO) Headlines

No Headlines